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Obesity is an increasingly prevalent and preventable morbidity with multiple behavioral, surgical and
pharmacological interventions currently available. Commercial dietary supplements are often advertised
to stimulate metabolism and cause rapid weight and/or fat loss, although few well-controlled studies
have demonstrated such effects. We describe a commercially available dietary supplement (purportedly
containing caffeine, catechins, and other metabolic stimulators) on resting metabolic rate in humans, and
on metabolism, mitochondrial content, and related gene expression in vitro. Human males ingested
either a placebo or commercially available supplement (RF) in a randomized double-blind placebo-
controlled cross-over fashion. Metabolic rate, respiratory exchange ratio, and blood pressure were
measured hourly for 3 h post-ingestion. To investigate molecular effects, human rhabdomyosarcoma
cells (RD) and mouse myocytes (C2C12) were treated with various doses of RF for various durations. RF
enhanced energy expenditure and systolic blood pressure in human males without altering substrate
utilization. In myocytes, RF enhanced metabolism, metabolic gene expression, and mitochondrial content
suggesting RF may target common energetic pathways which control mitochondrial biogenesis. RF ap-
pears to increase metabolism immediately following ingestion, although it is unclear if RF provides
beneﬁts beyond those provided by caffeine alone. Additional research is needed to examine safety and
efﬁcacy for human weight loss.
Copyright © 2015, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obesity is an increasingly prevalent morbidity with nearly two-
thirds of adult Americans overweight, with over 32% of men and
35% of adult women clinically obese.1 It is forecasted that roughly, Mitochondrial transcription
liferator-activated receptor g
, Respiratory exchange ratio;
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for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).85% of adult Americans will be overweight, over half of which will
be clinically obese by 2030.2,3 Over the past decade, chemical and
behavioral interventions that favorably modify metabolic rate have
been central to obesity research. Several over-the-counter dietary
supplements claim to increase metabolic rate and enhance fatty
acid catabolism.
Ripped Freak® (RF) from PharmaFreak (Toronto, Canada) is one
such commercially available dietary supplement advertised to act
as a thermogenic agent, although there appear to be no previously
published data on its efﬁcacy. RF is speciﬁcally purported to in-
crease metabolic rate, oxygen consumption, and fatty acid oxida-
tion. RF is also purported to modify signal transduction and
induction of genes that control energy homeostasis. Several of the
ingredients that purportedly comprise RF's proprietary blendrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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capsaicin; many of which have been previously linked to increased
metabolic rate (Table 1).
Previously, caffeine has been shown to increase metabolic rate
in humans and in cell culture.4e10 Human data suggests that
caffeine elicits a dose-dependent increase in resting metabolic
rate.9 In addition, dietary components (such as green tea) have
been shown to increase metabolism more effectively than caffeine
alone.4 Dietary supplements similar to RF were previously shown
to increase markers of fat mobilization, metabolic rate (measured
via indirect calorimetry), and reduce bodyweight and body fat
(estimated via Dual-energy X-ray absorptiometry) in healthy young
subjects following ingestion.11e18 Our laboratory recently identiﬁed
that treatment of cultured skeletal muscle with caffeine can in-
crease both metabolic rate and mitochondrial content in muscle
cells, suggesting that commercially available metabolic stimulators
may have similar effects.8 Caffeine is believed to work through
phosphodiesterase inhibition leading to increases in cAMP or
through increasing cytosolic Ca2þ.8,19,20 In addition, our lab recently
showed that treatment with either of two similar over-the-counter
supplements, or several other dietary components lead to
increased metabolic rate and mitochondrial content in skeletal
muscle cells.8,21e24 We have demonstrated, along with others, that
stimulation of metabolism by dietary components induces many
molecular adaptations including metabolic gene expression. Spe-
ciﬁcally, expression of peroxisome proliferator-activated receptor g
coactivator-1a (PGC-1a) is increased following administration of
various dietary stimulators of metabolism.8,22e24 PGC-1a is a
transcriptional coactivator that is essential for mitochondrial
biosynthesis and acts as a master regulator of energy homeostasis
and metabolism.25e27 Our group has previously reviewed the po-
tential role for dietary components in the stimulation of PGC-1a
and corresponding favorable metabolic adaptations for beneﬁt in
metabolic disease.28 Because skeletal muscle contributes largely to
total energy expenditure, and because it is highly responsive to a
variety of stimuli, skeletal muscle represents a meaningful target
for metabolic disease such as obesity and diabetes.28 This work
seeks to evaluate the acute effects of RF on energy expenditure in
healthy male human subjects, as well as investigate the molecular
effects of RF on skeletal muscle in vitro.Table 1
Purported composition of Ripped Freak®.
Ripped Freak® Formula 766.6 mga
Fat burning metabolism ampliﬁer 400 mga
Methyl EGCG™ (EGCG Derivative Stack) (Green Tea Extract/Camellia Sinensis)
Epigallocatechin-3-O-(3-O-Methyl) gallate Ester (EGCG 30 0Me)
Epigallocatechin-3-O-(4-O-Methyl) gallate Ester (EGCG 40 0Me)
40-O-Methyl-Epigallocatechin-3-O-Gallate Ester (EGCG 40Me)
Epigallocatechin-3-O-(3,4-O-Methyl) gallate Ester (EGCG 30 040 0diMe)
40-O-Methyl-Epigallocatechin-3-O-(4-O-Methyl) gallate Ester
(EGCG 4040 0diMe)
Oleuropein Aglycone (Olive Leaf Extract/Olea Europaea)
1,3,7-Trimethyl-1H-Purine-2,6(3H,7H)-Dione Methyl Gallate Ester
(Caffeine) (Coffee/Coffea Arabica, Whole Bean)
Uncoupling protein/oxygen utilization ampliﬁer 200 mga
CH-19 Sweet Red Pepper Ester Stack
(CH-19 Sweet Red Pepper Extract/Capsicum Annum, Fruit) (0.75% Capsiate)
4-Hydroxy-3-Methoxybenzyl (E)-8-Methyl-6-Nonenoate Ester
4-Hydroxy-3-Methoxybenzyl 8-Methyl-Nonanoate Ester
4-Hydroxy-3-Methoxybenzyl 7-Methyl-Octanoate Ester
Hormone sensitive lipase fat mobilization ampliﬁer 166.6 mga
4-(4-Hydroxyphenyl)-2-Methyl Ethyl Ketone (Raspberry Ketone)
4-(4-Hydroxyphenyl)-2-Butanone Methyl Gallate Ester
(Raspberry Ketone e Gallic Acid)
a Percent daily value not established.2. Materials and methods
2.1. In vivo
2.1.1. Human subjects
Healthy male volunteers aged 18e40 years were eligible for the
study. Participants were excluded if they were caffeine naïve, clini-
cally obese (BMI > 30 kg/m2), if they had known cardiovascular
disease, hypertension, or refused to adhere to subject-study pro-
cedures. Ten (n ¼ 10) eligible and willing participants were asked to
abstain from caffeine and/or dietary supplement consumption in
addition to rigorous exercise at least 48 hprior to eachmeasurement.
Participants were also asked not to consume anything but water and
not to smokeat least 12hprior to each studyvisit. Subject food intake
was recorded the day prior to initial metabolic measurements, and
subjects were asked to consume approximately the same meal
composition 24 h prior to the second measurement. Subjects
completed a health history questionnaire, food and beverage recall,
and informed consent as approved by the Institutional Review Board
(HRPO #13-066) and HIPAA. Participants reported their usual intake
of caffeinated beverages (coffee, tea, soft drink, energy drink, etc.)
with corresponding serving size, and were asked to list other regu-
larly consumed stimulants (such as those found in dietary supple-
ments or over the counter medications). Subject height, weight, and
resting blood pressure were recorded prior to initial metabolic
measurement. Body composition was estimated by 3 site skin-fold
measurements (chest, abdominal, and thigh) and estimated body
densitywasused to calculate body fatpercent using the Siri equation.
Descriptive subject data are listed in Table 2.
2.1.2. Human metabolic measurements
Each subject was asked to participate in two trials in a double-
blind-placebo-controlled cross-over design consisting of two
treatments (one placebo ﬁlled with dextrose and one serving of RF
constituting the actual treatment) for measurement of resting en-
ergy expenditure with at least 48 h between the two measure-
ments. Treatments were provided in a double-blind fashion by a
third party. Following anthropometric measurements, the subject
was asked to consume a blinded treatment which was followed by
a resting blood pressure measurement. Metabolic measurements
were taken at baseline, and at both 1 and 2 h following treatment
ingestion with blood pressure assessed prior to each metabolic
measurement. Resting energy expenditure (REE) and respiratory
exchange ratio (RER) were measured using a metabolic measure-
ment system (TrueOne 2400 from Parvo Medics, Sandy, UT)
following an overnight fast similar to previous reports.16 The
metabolic cart was calibrated daily per manufacturer guidelines
prior to each trial. Participants rested in a supine position in a
comfortable ambient temperature in a quiet and dark room.
Expired gas was collected by placing a clear hood over the partic-
ipant's head and upper torso area with plastic seal secured under
the subject. Flow rate was monitored by a designated research as-
sistant during the course of the test and maintained at a rate of
1e1.2% expired carbon dioxide per manufacture's protocol. Data
were collected for approximately 30 min per measurement and the
5 min duration which produced the lowest variability of REE data
was used for values of REE and RER for all tests. REE data were
transformed into kcals/kg/day for both total body weight and lean
body mass.
2.2. In vitro
2.2.1. Cell culture
Human rhabdomyosarcoma cells (RD) and mouse myocytes
(C2C12) were purchased from ATCC (Manassas, VA). Cells were
Table 2
Summary of subject (N ¼ 10) anthropometric variables and estimated caffeine
consumption.
Subject variable Average (±SD)
Age (years) 26.7 (±3.86)
Weight (kg) 77.75 (±8.56)
Height (cm) 175 (±5.0)
BMI (kg/m2) 25.34 (±2.65)
Body fat (%)a 14.78 (±6.7)
Lean body mass (kg) 65.97 (±6.05)
Caffeine consumption (mg/day)b 292.45 (±150.76)
a Body fat percent was estimated using the Siri equation from 3 site skin fold
measurements.
b Caffeine intake was estimated through 24 h recall food questionnaire and
caffeine content of food and beverage list published by theMayo Clinic available at:
http://www.mayoclinic.com/print/caffeine/AN01211/METHOD¼print.
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taining 4500 mg/L glucose and supplemented with 10% heat-
inactivated fetal bovine serum (FBS) and 100 U/mL penicillin/
streptomycin, in a humidiﬁed 5% CO2 atmosphere at 37 C. Ripped
Freak® (RF) from PharmaFreak was purchased over the counter and
was diluted to various concentrations in ethanol; doses for RD cells
contained 200 mg/ml or 100 mg/ml and doses for C2C12 cells con-
tained 20 mg/ml or 10 mg/ml all of which were determined through
pilot data. Cells were treated for various durations with a ﬁnal
concentration of ethanol of 0.1% for all treatments, which did not
alter cell viability (data not shown).
2.2.2. Metabolic assay
Cells were seeded overnight in 24-well culture plate from Sea-
Horse Bioscience (Billerica, MA) at density 5  105 cells/well (RD
cells) or 3 105 cells/well (C2C12 cells), treated and incubated for 3
or 6 h as described above. Following treatment, culture media was
removed and replaced with XF Assay Media from SeaHorse
Bioscience (Billerica, MA) containing 4500 mg/L glucose free of
HCO3 and incubated at 37 C. Per manufacturers' protocol, Sea-
Horse injection ports were loaded with oligomycin, an inhibitor of
ATP synthase which induces maximal glycolytic metabolism and
reveals endogenous proton leak (mitochondrial uncoupling) at a
ﬁnal concentration 1.0 mM. Oligomycin addition was followed by
the addition of carbonyl cyanide p-[triﬂuoromethoxy]-phenyl-
hydrazone (FCCP), an uncoupler of electron transport that induces
peak oxygen consumption (an indirect indicator of peak oxidative
metabolism) at ﬁnal concentration 1.25 mM. Rotenone was then
added in 1.0 mM ﬁnal concentration to reveal non-mitochondrial
respiration and end the metabolic reactions.29,30 Extracellular
acidiﬁcation, an indirect measure of glycolytic capacity, and oxygen
consumption, a measure of oxidative metabolism was measured
using the SeaHorse XF24 Extracellular Analyzer from SeaHorse
Bioscience (Billerica, MA). SeaHorse XF24 Extracellular Analyzer
was run using 8 min cyclic protocol commands (mix for 3 min, let
stand 2 min, and measure for 3 min) in triplicate.
2.2.3. Cellular ATP content
Cells were seeded overnight in a 6-well plate at density
1  106 cells/well and treated as described above for 24 h. The cells
were lysed in 1% CHAPS lysis buffer from Chemicon (Billerica, MA)
in PBS with Ca2þ and Mg2þ and the ATP-containing supernatant
was recovered. Samples were allocated into a 96-well plate with a
1:1 dilution of ATP Bioluminescence Reagent from Sigma (St. Louis,
MO) with a 100 mM ﬁnal volume and luminescence was measured
and normalized to serial dilutions of ATP. ATP concentrations were
normalized to cell density determined through hemocytometery
measured by staining cells with trypan blue from Sigma (St Louis,MO) with cell density estimated using a Countess™ cell quantiﬁ-
cation system from Invitrogen (Carlsbad, CA).
2.2.4. Quantitative real time polymerase chain reaction (qRT-PCR)
Following treatment and incubation as described above, the
total RNA was extracted using RNeasy Kit from Qiagen (Valencia,
CA), per manufacturer's protocol. Total RNA was quantiﬁed by
NanoDrop spectrophotometry. cDNA was synthesized from
5000 ng total RNA using the Retroscript™ RT kit from Ambion
(Austin, TX) according to manufacturer's instructions. PCR primers
were designed using Primer Express software from Invitrogen
(Carlsbad, CA) and synthesized by Integrated DNA Technologies
(Coralville, IA). Ampliﬁcation of PGC-1a, nuclear respiratory factor
(NRF-1), mitochondrial transcription factor A (TFAM), and glucose
transporter 4 (GLUT4) were normalized to the housekeeping gene,
TATA Binding Protein (TBP). Table 3 summarizes the forward and
reverse primers of each gene. qRT-PCR reactions were performed in
triplicate using the LightCycler 480 real-time PCR system from
Roche Applied Science, (Indianapolis, IN). SYBR Green based PCR
was performed in triplicate using 5000 ng of cDNA per sample;
ﬁnal primer concentrations were 10 mM in a total volume of 30 ml.
The following cycling parameters were used: 95 C for 10 min
followed by 45 cycles of 95 C for 15 s, and 60 C for 1 min. Relative
expression levels were determined by the DDCp method and
compared to the lowest expressing group as previously described.31
2.2.5. Flow cytometry
Cells were plated in 6-well plates at a density of 1.0  106 cells/
well treated in triplicate and incubated as previously described
above for 48 h. Following treatment, the media was removed and
the cells were re-suspended in pre-warmed media with 200 nM
MitoTracker Green from Life Technologies (Carlsbad, CA) and
incubated for 45 min in a humidiﬁed 5% CO2 atmosphere at 37 C.
The cells were pelleted, the media with MitoTracker was removed
and the cells were suspended in pre-warmed media. Group mean
ﬂuorescence was measured using Facscalibur ﬁltering 488 nm.
2.2.6. Microscopy and immunoﬂuorescence
To verify increased mitochondrial content, the cells were then
stainedwithMitoTracker 200 nM from Invitrogen (Carlsbad, CA) for
45 min, rinsed thoroughly, and ﬁxed in 3.7% formaldehyde in pre-
warmed media. Cells were mounted, cured and imaged as
described above. Slides weremountedwith Prolong Goldwith DAPI
from Invitrogen (Carlsbad, CA) and cured overnight. Cells were
imaged using the Axiovert 25 microscope with AxioCam MRc from
Zeiss (Thornwood, NY).
2.2.7. Cell viability
Cells were seeded in 96-well plates at density 5000 cells/well
and grown over night. Cells were treated and incubated as previ-
ously described for 24 h. Media and treatment were removed and
media containing 10% WST1 was added to each well and were
incubated as previously described. Fluorescence was measured 1 h
following WST1 addition using Wallac Victor3V 1420 Multilabel
Counter from PerkinElmer (Waltham, MA).
2.2.8. Statistical analysis
Cellular metabolic assays, metabolic gene expression, ﬂow
cytometry, and cell viability were analyzed using ANOVA with
Dunnett's post hoc test and pairwise comparisons were used to
compare treatments with control. Microscopy was analyzed using
student's t test. Human REE (kcal/hr/kg), RER (VCO2/VO2), and both
systolic and diastolic blood pressure responses were analyzed by
two-way repeated measures ANOVA. Correlations between age,
BMI, and self-reported caffeine consumptions were analyzed using
Table 3
Summary of qRT-PCR primers from Integrated DNA Technologies (Coralville, IA).
Primer name Forward sequence Reverse sequence
TBPH 50-CACGAACCACGGCACTGATT-30 50-TTTTCTTGCTGCCAGTCTGGAC-30
PGC-1aH 50-ACCAAACCCACAGAGAACAG-30 50-GGGTCAGAGGAAGAGATAAAGTTG-30
NRF-1H 50-GTATCTCACCCTCCAAACCTAAC-30 50-CCAGGATCATGCTCTTGTACTT-30
TFAMH 50-GGGAAGGAGGGTTGTGTATTT-30 50-AGGAGTTAGCCAAACGCAATA-30
GLUT4H 50-AAGAATCCCTGCAGCCTGGTAGAA-30 50-CCACGGCCAAACCACAACACATAA-30
TBPM 50-GGGATTCAGGAAGACCACATA-30 50-CCTCACCAACTGTACCATCAG-30
PGC-1aM 50-GACAATCCCGAAGACACTACAG-30 50-AGAGAGGAGAGAGAGAGAGAGA
NRF-1M 50-ACCCTCAGTCTCACGACTAT-30 50-GAACACTCCTCAGACCCTTAAC-30
TFAMM 50-GAAGGGAATGGGAAAGGTAGAG-30 50-ACAGGACATGGAAAGCAGATTA-30
GLUT4M 50-GGAGGGAGCCTTTGGTATTT-30 50-CAGGCGAGGACACTCATCTT-30
Abbreviations: peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1a), nuclear respiratory factor 1 (NRF-1), mitochondrial
transcription factor A (TFAM), and glucose transporter 4 (GLUT4) and TATA binding protein (TBP). H indicates for primers for human RNA and M indicates
primers for mouse RNA.
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cance in all tests. Prism from GraphPad (La Jolla, CA) was used to
perform all statistical analyses.
3. Results
3.1. In vivo
3.1.1. RF enhances resting energy expenditure
To evaluate the effects of RF consumption on metabolic rate in
humans, we measured REE following ingestion of either a single
serving of RF or a placebo (in a random double-blinded fashion). RF
increased REE during initial measurement, and 1 and 2 h post-
ingestion as well as average energy expenditure for the entire
trial compared with the control treatment (Fig. 1a). These ﬁndings
were observed using total energy expenditure and after controlling
for lean bodymass. RF consumptionwas associatedwith an average
increase in daily REE of 159.7 ± 89.7 kcal/day. Surprisingly, RER was
signiﬁcantly elevated in the RF-treated trial compared with placebo
treatment (Fig. 1b). Additionally, we measured the effects of RF
consumption on resting blood pressure. RF treatment signiﬁcantly
elevated systolic blood pressure throughout the trial, however RF
treatment did not alter diastolic blood pressure (Fig. 1c and d,
respectively). To investigate the contribution of subject variables
(summarized in Table 1) on response to RF, we assessed relation-
ships between age, BMI, and prior self-reported caffeine con-
sumption, none of which were signiﬁcant predictors of metabolic
response to RF (data not shown).
3.2. In vitro
3.2.1. RF enhances oxidative metabolism
To investigate the molecular effects of RF on skeletal muscle,
oxidative metabolism was measured in multiple myocyte cell
models following treatment with various doses of RF for several
durations. Treatment with RF for either 3 or 6 h signiﬁcantly
increased basal oxygen consumption in both cell models (Fig. 2a).
Peak oxidative metabolism was also signiﬁcantly increased in both
cell models following 3 h of treatment, but was only signiﬁcantly
elevated in the C2C12 cell model following 6 h of treatment sug-
gesting a differing response between the models with time-
dependence (Fig. 2b). In correspondence with basal oxidative
metabolism, cells treated with RF also exhibited signiﬁcantly
greater mitochondrial uncoupling (proton leak) (Fig. 2c).
3.2.2. RF alters glycolytic metabolism and metabolic reliance
To investigate the effects of RF treatment on glycolytic meta-
bolism, we measured extracellular acidiﬁcation rate. Interestingly,
RF-treated RD cells either displayed no change or a reducedglycolytic rate while RF-treated C2C12 cells exhibited a massive
increase in basal glycolysis compared with corresponding controls
(Fig. 2d). This discrepancy between the two cell models was also
seen during chemically induced peak glycolysis. Speciﬁcally, RD
cells treated with RF exhibited signiﬁcantly reduced glycolysis at
both 3 and 6 h. Conversely, C2C12 cells treated with RF showed
signiﬁcantly elevated peak glycolytic metabolism (Fig. 2e). Because
cells were cultured in high-glucose media (per ATCC recommen-
dations), and because RD cells exhibited a dynamic increase in
oxidative metabolism, we interpret the reduction in cellular acidi-
ﬁcation to indicate more complete carbohydrate metabolismwhich
our group has previously described.24 Despite discrepancies in
glycolytic response between the 2 cell models, both cell types
exhibited a signiﬁcantly increased reliance on oxidative meta-
bolism (expressed as a ratio of OCR:ECAR) when compared with
respective controls (Fig. 2f).
3.2.3. RF induces metabolic gene expression
To investigate the effects of RF treatment on metabolic gene
expression, wemeasured relative RNA expression of PGC-1a, NRF-1,
TFAM, and GLUT4 expression normalized to TBP following treat-
ment with RF for 4, 12, and 24 h. RD cells treated with RF exhibited
signiﬁcantly elevated PGC-1a expression at initial time points
(Fig. 3a) while C2C12 cells only exhibited elevated PGC-1a expres-
sion following 4 h of treatment (Fig. 3b). RF also signiﬁcantly
induced NRF-1 and TFAM expression, downstream targets of PGC-
1a, in both cell models. Additionally, GLUT4 expressionwas elevated
above control levels at various time points for both cell models the
most notable of which occurred at 24 h. In addition to heightened
metabolic gene expression in RF treated cells, RF treatment was also
associated with signiﬁcantly elevatedmitochondrial content in both
cell models, measured by both ﬂow cytometry and confocal mi-
croscopy (Fig. 3c and d, respectively). In addition, RF treatment
caused a signiﬁcant reduction in cellular ATP content for C2C12
myocytes without altering ATP content of RD cells (Fig. 3e).
4. Discussion
Few published data are available regarding the effects of RF (or
similar dietary supplements) on metabolism. Our data are among
the ﬁrst observations to describe both the molecular and physio-
logical effects of RF which include increased cellular metabolism
with enhanced mitochondrial uncoupling in vitro. Interestingly, our
observations demonstrate that RF-treated muscle cells consistently
exhibited greater basal oxidative and total metabolism accompa-
nied by a signiﬁcant increase in peak oxidative capacity. Our data
also demonstrate that RF signiﬁcantly induced metabolic gene
expression including PGC-1a, which was accompanied by a sig-
niﬁcant increase in mitochondrial content in both cell models. An
Fig. 1. Metabolic Rate and Substrate Utilization. (A) Resting energy expenditure (REE) of human male subjects following ingestion of either a placebo (control) or a single serving of
RF. (B) Respiratory exchange ratio (RER) of human male subjects following ingestion of either a placebo (control) or a single serving of RF. (C) Systolic blood pressure of human male
subjects following ingestion of either a placebo (control) or a single serving of RF. (D) Diastolic blood pressure of human male subjects following ingestion of either a placebo
(control) or a single serving of RF. NOTES: * indicates p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001 compared with control.
Fig. 2. Cellular Metabolism. (A) Basal oxidative metabolism indicated by oxygen consumption rate (OCR) of RD (left) cells treated with either ethanol control or RF at 100 mg/ml or
200 mg/ml for 3 or 6 h and C2C12 (right) cells treated with either ethanol control or RF at 10 mg/ml or 20 mg/ml for 3 or 6 h. (B) Peak OCR of RD and C2C12 cells following addition of
oligomycin following treatment as described in A. (C) Mitochondrial uncoupling (endogenous mitochondrial proton leak) of RD and C2C12 cells treated as described in A. (D) Basal
glycolytic metabolism indicated by extracellular acidiﬁcation rate (ECAR) of cells treated as described above. (E) Peak ECAR of RD and C2C12 cells following the addition of oli-
gomycin following treatment as described above. (F) Metabolic reliance expressed as a ratio of OCR:ECAR. NOTES: * indicates p < 0.05, ** indicates p < 0.01, and *** indicates
p < 0.001 compared with control.
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concentration than the non-malignant myocytes, suggesting that
RD cells are substantially more resilient. Moreover, the cancerous
phenotype that RD cells possess (causing RD cells to preferentially
select glycolytic metabolism over oxidative metabolism) may also
explain the differential response in glycolytic metabolism between
the cell models. These observations highlight potential issues
(including cell model discrepancies) with experiments using
in vitro observations alone.
The discrepancy between cell model ATP response is a mean-
ingful observation because reduced cellular ATP content is a potentstimulus for cells and is likely in part responsible for the heightened
metabolic activity with related gene expression. Not surprisingly,
non-malignant C2C12 myocytes exhibited signiﬁcantly reduced
ATP content and a larger relative increase in both oxidative and
glycolytic metabolism. One limitation of this work is that the spe-
ciﬁc upstream signaling targets of PGC-1a were not evaluated.
However, the effect of caffeine and reduced cellular ATP content on
5-adenosine monophosphate-activated protein kinase (AMPK)
activation are well documented, making AMPK a strong candidate
responsible for increases in energy expenditure and PGC-1a
expression.32,33 Additionally, because oxidativemetabolism ismore
Fig. 3. Metabolic Gene Expression. (A) Gene expression of RD cells treated with either ethanol control or RF at 100 mg/ml or 200 mg/ml for 4, 12, or 24 h of PGC-1a, NRF-1, TFAM, and
GLUT4. (B) Gene expression of C2C12 cells treated with either ethanol control or RF at 10 mg/ml or 20 mg/ml for 4, 12, or 24 h of PGC-1a, NRF-1, TFAM, and GLUT4. (C) Mitochondrial
content indicated by group mean log ﬂuorescence from ﬂow cytometry of RD (left) and C2C12 cells (right) treated as described in methods for 24 h stained with MitoTracker green.
(D) Group mean log ﬂuorescence of confocal microscopy of RD cells treated as previously described for 24 h. (E and F) Representative images from ﬂuorescent confocal microscopy
of RD cells (E) and C2C12 cells (F) treated as described above. Fluorescent measurements were performed using N ¼ 7 cells/treatment which were stained with MitoTracker (green)
and DAPI (blue). (G) Cellular ATP content following treatment of either RD cells (left) or C2C12 cells (right) with RF at various doses for 24 h. NOTES: * indicates p < 0.05, ** indicates
p < 0.01, and *** indicates p < 0.001 compared with control. White measurement bar represents 50 mm.
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reduced efﬁciency of oxidative ATP production) is a necessary effect
of potential anti-obesity agents. Our data suggests that RF reduces
ATP production in part by promoting mitochondrial uncoupling.
Despite this observation, it remains unclear if RF-induced mito-
chondrial uncoupling is sufﬁcient to compensate for increased ATP
production from oxidative metabolism. Cumulatively, the in vitro
ﬁndings are similar to several other studies performed by our labwhich showed that various dietary constituents can increase cell
metabolism and mitochondrial content in skeletal muscle
cells.8,22,23 These observations also parallel those of other previous
investigations that measured the effects of dietary stimulants such
as caffeine on similar metabolic parameters in L6 myotubes and
C2C12 myocytes.19,34,35
In agreement with previous in vivo observations using similar
dietary supplements, RF appears to increase metabolic rate in
R.A. Vaughan et al. / Journal of Traditional and Complementary Medicine 7 (2017) 1e8 7young and healthy adult male subjects.16e18 Although RF treatment
elevated energy expenditure by approximately 160 kcals/day (as
estimated from our 3 h measurements), this estimate may be
inﬂated due to the time points measured (measurements closer to
initial consumption yield greater increases in metabolism) and
provide negligible beneﬁt for weight loss. Several similarities exist
between supplements designed to stimulate metabolism including
stimulants such as caffeine which have previously been docu-
mented to increase metabolism in humans.4,5,7,9,36 We have
recently discussed many of these similarities including ingredient
composition and effect on resting energy expenditure.37 Despite
these ﬁndings, it is unclear to what extent energy expenditure is
increased for the purpose of weight loss. Because our measure-
ments in human subjects were limited to 3 h following consump-
tion, several questions remain unanswered about the effects of RF.
First, at what point after a single dose does resting energy expen-
diture return to normal? Are these effects diminished with ongoing
use (sensitization)? Are these effects also seen in older adults and/
or women? Will increases in systolic blood pressure resolve with
use? Another primary limitation of our work is that it is unclear if
RF provides any metabolic beneﬁt beyond that previously docu-
mented by caffeine or catechin consumption. Another limitation is
that this study only measured the metabolic consequences of RF
consumption during resting state, however many of the metabolic
beneﬁts of caffeine occur as a result of increased muscular activity,
suggesting our ﬁndings may not reveal the complete metabolic
effect(s) of RF during activities of daily living. Despite these and
other limitations, our data adds to the current literature which
supports the hypothesis that dietary composition of select food
chemicals may play a vital role in human energy homeostasis and
energy balance. Proprietary blends consisting of multiple plant
extracts potentially offer numerous diverse phytochemicals which
may be useful in altering energy expenditure, although promo-
tional advertising makes current information difﬁcult for con-
sumers to trust. There currently exists an immense interest in both
private and commercial sectors for exploring extracts (such as
green tea (綠茶lǜ cha)) and other food chemicals for the beneﬁt of
metabolic diseases including obesity and diabetes supporting the
need for ongoing research in dietary supplements and functional
food chemicals.36
5. Conclusion
Dietary supplements are generally regarded as ineffective,
under-researched, and potentially risky by the medical community.
Despite this consensus, increasing consumer interest in alternative
methods to increase metabolism and fat loss warrants further
investigation into dietary supplements and thermogenic agents.
Our observations suggest RF may be effective at increasing meta-
bolic rate in vivo and in vitro; although from the current data it is
doubtful RF provides beneﬁts beyond those provided by natural
dietary sources of ingredients found in RF. It is also unclear if reg-
ular consumption of RF will cause signiﬁcant weight/fat loss in
healthy subjects. Further research is needed to elucidate the full
effects of habitual RF consumption on human metabolism and
health.
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